Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

NIH reports interferon is ineffective in hospitalised Covid-19 patients
NIH reports interferon is ineffective in hospitalised Covid-19 patients
The National Institutes of Health (NIH) in the US has reported that interferon beta-1a in combination with remdesivir did not boost outcomes in an ACTT-3 clinical trial in hospitalised adult C...
Akero Therapeutics Receives FDA Fast Track Designation for Efruxifermin (EFX) for the Treatment of NASH
Akero Therapeutics Receives FDA Fast Track Designation for Efruxifermin (EFX) for the Treatment of NASH
SOUTH SAN FRANCISCO, Oct.
Despite legal troubles, Johnson & Johnson is in the financial driver's seat for 2022 and beyond, CFO says
Despite legal troubles, Johnson & Johnson is in the financial driver's seat for 2022 and beyond, CFO says
Headlines about its underachieving COVID-19 vaccine, its attempts to resolve opioid and talc litigation and the coming departure of CEO Alex Gorsky suggest that it has been a difficult year for Johnso...
FDA delays decision on Moderna's COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ
FDA delays decision on Moderna's COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ
FDA delays decision on Moderna's COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ After reports in four Nordic countries of the heart inflammation condition myocarditis, th...
Vertex’s type 1 diabetes therapy hits the mark in Phase I/II study
Vertex’s type 1 diabetes therapy hits the mark in Phase I/II study
Vertex Pharmaceuticals has revealed ‘remarkable’ data from an early-stage study evaluating its stem-cell derived therapy VX-880 in type 1 diabetes (T1D).
FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
The U.
New asthma drug approved on NHS branded a ‘wonder drug
New asthma drug approved on NHS branded a ‘wonder drug
NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma.
FDA approves Oyster Point's nasal spray for dry eye disease
FDA approves Oyster Point's nasal spray for dry eye disease
Oct 18 (Reuters) - Drug developer Oyster Point Pharma Inc OYST.
Experts warn that expensive COVID-19 pill and stockpiling could cause treatment inequality
Experts warn that expensive COVID-19 pill and stockpiling could cause treatment inequality
The antiviral pill Molnupiravir produced by U.
FDA Grants Fast Track Designation to AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
FDA Grants Fast Track Designation to AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
LA JOLLA, Calif.
One coronavirus vaccine may protect against other coronaviruses
One coronavirus vaccine may protect against other coronaviruses
Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient.
NICE clears Opdivo for resected oesophageal or gastro-oesophageal junction cancer
NICE clears Opdivo for resected oesophageal or gastro-oesophageal junction cancer
The UK National Institute for Health and Care Excellence (NICE) has recommended Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) as a treatment option for certain resected oes...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand